Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.
about
Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial HypertensionComparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activityPlasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsAngiotensin II-mediated microvascular thrombosis.Bioactive angiotensin peptides: focus on angiotensin IV.The Association of the Metabolic Syndrome with PAI-1 and t-PA LevelsAdipose inflammation, insulin resistance, and cardiovascular diseaseCoagulation and fibrinolysis abnormalities in obesity.Autonomic and endocrine control of cardiovascular functionSecretory factors from human adipose tissue and their functional role.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.Adipose tissue metabolism, diabetes and vascular disease--lessons from in vivo studies.Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.Human plasma kallikrein-kinin system: physiological and biochemical parametersDoes interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms.Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability.Efficacy of flavonoids in the management of high blood pressure.Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.Valsartan: the past, present and future.Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes.Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism.Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension.Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway.11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women.Comparative proteomic analysis of the insulin-induced L6 myotube secretome.Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion.The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome
P2860
Q26747017-EF24DD75-CB0A-4B92-8621-AA8907DBCD27Q30931167-5711C64B-D1A5-4F44-8AFB-DEC494BA0C43Q34018895-8F44F1A9-B8F7-410F-A147-B0B5DFE7A92FQ34171310-5FD9700A-501B-4AF1-B3D7-0FF33F0E6641Q34217461-46A7C111-A616-486E-8B97-5C44E4416B9EQ34502226-A888D0D0-40A5-49C0-AF13-1F1144C9D063Q34553630-0AD6CFB6-BCB1-4CE0-A320-89169EDE66CCQ34929646-6B1CC7FB-16E7-4175-BF0C-3196C04581F9Q34931211-78D5ADD7-C088-41E5-A0CE-C372A91B77DFQ35037271-4BF6B2E0-BA99-48D6-9D43-5836620112D2Q35501160-5B71E9A6-9A13-45D5-9CAC-C9D548900905Q36165333-E3CC1AB8-251D-41DC-9183-B45812B27DA8Q36241932-892FEEE4-A848-428A-A0DB-56D4DC2814CFQ36415843-1DF8D190-6B4F-41A6-9FEA-26034ACDB8E3Q36511220-D9059EBC-CA42-4E1A-BE54-34CD59EC6B8DQ36649671-12D208FA-38D9-4AAB-9AC9-7277DCDC2CD1Q36998879-CD619ADF-E8B9-45B2-8551-7034A5BB1976Q37973874-7F235F4A-DB04-48CD-80DF-A1C7CEAAAC99Q38020530-9627BEA8-085B-49C6-8970-12F5028B8422Q38263804-F2710E8E-8AF2-4F2F-ACF4-C46CD8624309Q38613682-F8A0A67A-AB79-479E-8B26-8BADE33A0ED4Q39220804-051E57DA-6B39-4D38-A818-AB3621C4EB6DQ39315148-A7A99C71-0493-4C91-A384-68FAFD0C71F9Q40393678-32C88213-CF66-4945-8B2E-39AE4624C296Q41339839-EF42883F-B4AE-45D0-B5D5-E8D6CD0EA7B3Q42495467-FAD02B6D-C781-4284-819F-1F6475C9EA8EQ43830021-F00CAA27-A786-425B-907A-D4661BB24E6BQ44700365-01F2F3B5-F6F5-4DEE-8AF9-E33FD51D94AEQ46564722-E39507D2-2F5C-4534-9004-55B3340A49AAQ46929674-7FF97BBC-A995-48F5-88D6-3ECEC52B2109Q47200207-945EB83D-59D5-449C-B071-69703EBDCF99Q51491433-3D97D75A-BF30-4400-88EE-D1F5E0315278Q52948768-EBD17FB8-E4B4-42C9-88E0-F834CC042F88Q57423553-49F498BB-151C-48E0-A021-770876A21E0F
P2860
Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Angiotensin II and its metabol ...... adipocytes in primary culture.
@ast
Angiotensin II and its metabol ...... adipocytes in primary culture.
@en
type
label
Angiotensin II and its metabol ...... adipocytes in primary culture.
@ast
Angiotensin II and its metabol ...... adipocytes in primary culture.
@en
prefLabel
Angiotensin II and its metabol ...... adipocytes in primary culture.
@ast
Angiotensin II and its metabol ...... adipocytes in primary culture.
@en
P2093
P356
P1433
P1476
Angiotensin II and its metabol ...... adipocytes in primary culture.
@en
P2093
P304
P356
10.1161/01.HYP.37.5.1336
P407
P577
2001-05-01T00:00:00Z